Helping people with COVID-19 avoid blood clots

It seems like every week new data comes out about blood clots in patients with COVID-19. Thrombosis puts someone hospitalized for COVID-19 more at risk...

This type of mask most effective against COVID-19

In a new study, researchers suggest that if you are going to buy a face mask to protect yourself and others from COVID-19, make...

After old age, the thing is biggest risk factor for COVID-19 death

Intellectual disability puts people at higher risk of dying earlier in life than the general population, for a variety of reasons. The main symptom is...

This thing may increase death risk in pneumonia, flu and COVID-19

In a recent study at the University of Michigan, researchers found that high levels of cadmium, a chemical found in cigarettes and in contaminated...

This new drug 10 times more effective fighting COVID-19

In a recent study from UCL and elsewhere, researchers found that the antiviral drug plitidepsin is between 10 and 100 times more effective against...

Moderna COVID-19 vaccine may cause this skin reaction, study finds

The speed and scale of vaccinations against the SARS-CoV-2 virus ramps up globally. In a new paper, researchers call for greater awareness and communication around...

COVID-19 antibodies, vaccines less effective against new variants

In a new study, researchers found that three new, fast-spreading variants of the virus that cause COVID-19 can evade antibodies that work against the...

This study finds why blood type matters for COVID-19 infection

In a new study, researchers found further evidence that people with certain blood types may be more likely to contract COVID-19. They found that the...

How one caregiver keeps his dad safe from COVID-19

As COVID-19 vaccination moves forward, limiting the number of serious illnesses and deaths from this disease remains vital. For those who are caring for someone...

Single vaccine dose may protect people who have had COVID-19

In a new study, researchers found that those who have previously experienced a SARS-CoV-2 infection develop a strong antibody response to the first dose...